Skip to Main Content

Paper Details

Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes.
Lancet Diabetes and Endocrinology,The
49
2020
Author NameAffiliation
Jaap Jan ZwagingaLeiden University Medical Center
  • 1 - 1

Datasets

Release 1.2